Latest Breaking News On - Bolt biotherapeutics company profile - Page 1 : comparemela.com

Short Interest in Bolt Biotherapeutics, Inc (NASDAQ:BOLT) Grows By 12 6%

Bolt Biotherapeutics, Inc. (NASDAQ:BOLT – Get Free Report) was the recipient of a significant increase in short interest in March. As of March 15th, there was short interest totalling 1,960,000 shares, an increase of 12.6% from the February 29th total of 1,740,000 shares. Currently, 8.2% of the shares of the stock are short sold. Based […]

Bolt biotherapeutics company profileBolt biotherapeutics incJpmorgan chase coNewtyn managementGeode capital managementYork mellon corpGet free reportNew york mellon corpCapital managementOccudo quantitative strategiesQuantitative strategiesBolt biotherapeuticsNasdaq bolt

Equities Analysts Offer Predictions for Bolt Biotherapeutics, Inc s Q1 2024 Earnings (NASDAQ:BOLT)

Equities Analysts Offer Predictions for Bolt Biotherapeutics, Inc s Q1 2024 Earnings (NASDAQ:BOLT)
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

Bolt biotherapeutics company profileTower research capitalPrudential financial incJpmorgan chase coBolt biotherapeutics incCubist systematic strategiesFree reportSystematic strategiesResearch capitalGet free report

Bolt Biotherapeutics (NASDAQ:BOLT) Shares Pass Above 200 Day Moving Average of $1 10

Bolt Biotherapeutics (NASDAQ:BOLT) Shares Pass Above 200 Day Moving Average of $1 10
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Edgar englemanYork mellon corpTower research capitalGeode capital managementBolt biotherapeutics incBolt biotherapeutics company profileVivo capital viii llcGet free reportVivo capital viiiDirector edgar englemanQuantitative strategiesNew york mellon corpResearch capitalCapital management

Bolt Biotherapeutics (NASDAQ:BOLT) Stock Passes Above 200-Day Moving Average of $1 49

Bolt Biotherapeutics, Inc. (NASDAQ:BOLT – Get Rating)’s stock price passed above its 200-day moving average during trading on Thursday . The stock has a 200-day moving average of $1.49 and traded as high as $1.71. Bolt Biotherapeutics shares last traded at $1.66, with a volume of 83,728 shares. Analysts Set New Price Targets A number […]

Bolt biotherapeutics company profileCubist systematic strategiesTower research capitalPrudential financial incBolt biotherapeutics incJpmorgan chase coGet ratingSystematic strategiesResearch capital

Susquehanna International Group LLP Takes $26,000 Position in Bolt Biotherapeutics, Inc (NASDAQ:BOLT)

Susquehanna International Group LLP purchased a new stake in shares of Bolt Biotherapeutics, Inc. (NASDAQ:BOLT – Get Rating) in the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm purchased 20,307 shares of the company’s stock, valued at approximately $26,000. Susquehanna International Group LLP owned approximately 0.05% […]

Jpmorgan chase coSecurities exchange commissionPrudential financial incSusquehanna international groupBolt biotherapeutics incTower research capitalCubist systematic strategiesMorgan stanleyBolt biotherapeutics company profileGet ratingInternational groupResearch capitalSystematic strategiesVisit holdingschannelBolt biotherapeuticsNasdaq bolt